Get the latest tech news

FDA Warns GLP-1s May Increase Risk of Sudden Blindness


An anonymous reader quotes a report from NBC News: The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness. The condition, called nonarteritic anterior ischemic optic neuropathy, or NAION, affects the opti...

None

Get the Android app

Or read this on Slashdot

Read more on:

Photo of FDA

FDA

Photo of risk

risk

Photo of glp-1s

glp-1s

Related news:

News photo

FDA Orders New Vision Loss Warning for Ozempic and Other GLP-1s

News photo

Japanese homeware giant pulls online store after cloud breach puts 7.7M records at risk

News photo

Businesses are putting themselves at risk of cyberattacks — by recovering too fast